SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging on massive trading volume as investors react to a blowout earnings report featuring substantial revenue growth, record-setting order backlogs, and aggressive future revenue guidance that has fueled short-squeeze speculation. The community is actively debating the stock's valuation disconnect, with bulls calling for a major price re-rating toward the triple digits while emphasizing that strong operational fundamentals and enterprise demand should overpower lingering regulatory and accounting concerns.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is surging as investors cheer a massive revenue beat and strong AI cloud growth, triggering a significant short squeeze that has left bearish traders scrambling to cover. The community is heavily focused on the stock's aggressive price action and momentum, while many are actively debating the sustainability of its high valuation against the backdrop of its rapid infrastructure expansion.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is drawing significant attention following CEO Mark Zuckerberg's latest manifesto on AI, which emphasizes open-source innovation and the launch of new lightweight AI models, fueling speculation about future growth and strategic direction. While the stock continues to attract active community debate regarding its heavy capital expenditure and legal headwinds, traders are closely watching its recent consolidation patterns for potential breakout opportunities.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is trending as investors aggressively drive a short squeeze, bolstered by the company's new AI software release and sustained institutional buying. The community is sharply divided, with bulls celebrating the stock's recovery above its IPO price while bears express caution regarding valuation and upcoming share lock-up expirations.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's shares are trending amid reports that activist investor Nelson Peltz is preparing a bid to take the company private. The market is actively discussing the potential buyout price and a possible short squeeze, as bullish retail investors bet against the high short interest.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is attracting intense community attention as traders weigh its pivot toward AI infrastructure against high short interest, with many focused on potential upside from its expanded data center capacity and revenue growth. Investors are actively debating the timing of a possible short squeeze as they look for further contract announcements to validate the company's long-term AI strategy.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is currently facing intense selling pressure and high volatility following a revenue miss and subsequent analyst downgrades, fueling community debate over whether this represents a major buying opportunity or the start of a deeper valuation reset. Investors are actively discussing the stock's significant year-to-date decline, the impact of potential share buybacks, and the company's long-term profitability despite concerns over growth sustainability.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is seeing increased investor activity and volatility as the stock reacts to a strong quarterly earnings report that exceeded revenue and EPS expectations. The community is actively discussing the stock's significant price momentum, the potential long-term benefits of the ongoing AI infrastructure buildout, and the broader implications for the optical networking sector.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending following a significant second-quarter earnings beat and an upward revision to its full-year revenue guidance, fueled by robust organic growth and its recent acquisition of SkyWater Technology. While the community remains divided between long-term bulls highlighting major defense contracts and bears questioning the stock's valuation relative to profitability, investors are heavily focused on the company's expanding backlog and the upcoming investor day as key catalysts for future momentum.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending after reporting positive Phase 3 results for DT120 in major depressive disorder, with the community now focusing on upcoming Phase 3 readouts for generalized anxiety disorder as potential catalysts for further value. Investors are actively debating the company's valuation, clinical differentiation, and the potential for regulatory approval amidst significant institutional interest and a recent secondary offering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, and Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced a multi-part collaboration including...

BeOne Medicines Ltd. - Sponsored ADR  (ONC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for BeOne Medicines Ltd. - Sponsored ADR  (ONC) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the second quarter of 2026. John V. Oyler, Co-Founder, Chairman, and CEO, BeOne, said: These strong second-quarter results underscore our continued...

Insider Selling: Chan Henry Lee Unloads $337K Of BeOne Medicines Stock

On August 3, a recent SEC filing unveiled that Chan Henry Lee, SVP at BeOne Medicines (NASDAQ:ONC) made an insider sell.
What Happened: Lee's recent move involves selling 1,044 shares of BeOne Medicines. Thisread more...

Countdown to BeOne Medicines Ltd. - Sponsored ADR  (ONC) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for BeOne Medicines Ltd. - Sponsored ADR  (ONC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.

BeOne Medicines Expands U.S. Manufacturing with Total Investment of More Than $1 Billion to Advance Innovative Cancer Medicines

BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a $300 million expansion of its flagship clinical and commercial-stage manufacturing and research and development center at the Princeton West Innovation Campus in Hopewell, New Jersey...

BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the Phase 3 MANGROVE study (BGB-3111-306; NCT04002297) evaluating foundational BTK inhibitor BRUKINSA (zanubrutinib) plus rituximab versus bendamustine plus...

Insider Decision: Henry Chan Lee Offloads $156K Worth Of BeOne Medicines Stock

On June 18, a recent SEC filing unveiled that Henry Chan Lee, SVP at BeOne Medicines (NASDAQ:ONC) made an insider sell.
What Happened: Lee's decision to sell 590 shares of BeOne Medicines was revealed in a Form 4read more...

President and COO At BeOne Medicines Sells $361K Of Stock

It was reported on June 18, that Xiaobin Wu, President and COO at BeOne Medicines (NASDAQ:ONC) executed a significant insider sell, according to an SEC filing.
What Happened: Wu opted to sell 1,357 shares of BeOneread more...

Insider Selling: JOHN OYLER Unloads $980K Of BeOne Medicines Stock

Revealing a significant insider sell on June 18, JOHN OYLER, Chief Executive Officer at BeOne Medicines (NASDAQ:ONC), as per the latest SEC filing.
What Happened: OYLER's recent move involves selling 3,693 shares ofread more...

$ONC Q2 '26 Earnings Results & Recap

BeOne Medicines Ltd. raised its 2026 total revenue guidance to $6.6 billion to $6.8 billion, with GAAP operating income of $1.0 billion to $1.1 billion and non-GAAP operating income of $1.7 billion to $1.8 billion.

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

BeOne Medicines Ltd - ADR

ONC Stock Gains As BeOne Medicines Wins US Nod For BEQALZI In Rare Lymphoma

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ONCBeOne Medicines Ltd - ADR

Fundamentals

Connect Stocktwits to ChatGPT

Latest ONC News